Alimera Sciences Adds Dr. Glen Bradley to Its Board of Directors

Biopharmaceutical company Alimera Sciences, which develops prescription ophthalmic pharmaceuticals, has appointed Dr. Glen Bradl... [more]

View complete Press Release article